⌕
Medpace Holdings · MEDP · Nasdaq
Tenet 59 · Mixed
Compare
$653.09+0.75%At closeTenet 59 · Mixed
$653.09+4.89 (+0.75%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Medpace Holdings (MEDP) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice

20 figures withheld by our checks. Each blank figure names its reason.

Business engineGrowing fast: revenue compounds ~22.0%/yr (FY21→FY25), net margin 17.8%, and free cash flow (~$681.9M) tracks net income. Earnings are cash, not paper. Worth your attention in FY25: Returns vs FCF (135%). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲20.0%
2,530.2
FY21→FY25CAGR +22.0%/yr
Net income ($M)▲11.6%
451.1
FY21→FY25CAGR +25.5%/yr
Free cash flow ($M)▲19.2%
681.9
FY21→FY25CAGR +30.5%/yr
Diluted EPS▲21.0%
15.28
buyback-liftedCAGR +33.5%/yr
What the receipts whisper · what a headline number hides
Share count
−21.7%

37.7mn → 29.5mn diluted shares since FY21. Part of EPS growth is the shrinking denominator. Watch net income too.

Capex
$31.4M

steady at 1.2% of revenue (−14.2% YoY).

Returns vs FCF
135%

$917.4M returned vs $681.9M of FCF in FY25. The gap comes off the balance sheet (see net cash).

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)2530.2Revenue0.0COGS−197.6SG&A534.9Op income−83.8Tax & other451.1Net income

18¢ of every revenue dollar becomes profit.

Margin trend · direction beats level Operating Net
30231580%sector median net margin ~3%FY21FY25

Net margin 17.8% is more than double the sector median. This filer reports no gross profit line, so that margin is not drawn.

The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
2,838.42,530.22,109.11,885.81,460.01,142.4▲20.0%+22.0%
Cost of revenue
—0.00.00.00.00.0——
Gross profit
—A—A—A—A—A—A——
Selling, general & admin
192.7197.6180.2161.4131.4108.4▲9.6%+16.2%
Total operating expenses
2,231.21,995.31,662.21,549.01,181.3943.8▲20.0%+20.6%
Operating incomefeeds ROC rank
607.1534.9446.9336.8278.7198.6▲19.7%+28.1%
Other income, net
19.97.429.1−1.14.23.2——
Pretax income
627.0542.4475.9335.7282.9201.9▲14.0%+28.0%
Income tax
109.291.371.552.937.520.0▲27.6%+46.1%
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings
517.8451.1404.4282.8245.4181.8▲11.6%+25.5%
Per share
Diluted EPSbuyback-sensitive
18.0215.2812.638.887.284.81▲21.0%+33.5%
Diluted shares (mn)
28.3729.5332.0131.8433.6737.70▼7.8%−5.9%
Margins
Gross margin
—A—A—A—A—A—A——
Operating margin
21.4%21.1%21.2%17.9%19.1%17.4%▼0.0pp+3.8pp
Net margin82nd pct in Healthcare
18.2%17.8%19.2%15.0%16.8%15.9%▼1.3pp+1.9pp
† TTM = trailing four quarters through 2026-09-30.A Withheld: cost of revenue is not on file, so the gross margin is not measured.
FY15 – FY20 · 6 more years
Unlock the full history →
5 more years of statements and CSV export are on Premium, and 6 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-10 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Medpace Holdings' revenue last fiscal year?

Medpace Holdings reported revenue of $2,530.2M in fiscal 2025, up 20.0% from fiscal 2024.

What was Medpace Holdings' net income?

Medpace Holdings reported net income of $451.1M in fiscal 2025, a net margin of 17.8%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.